Literature DB >> 31731257

To control or to be controlled? Dual roles of CDK2 in DNA damage and DNA damage response.

Qi Liu1, Jinlan Gao1, Chenyang Zhao1, Yingying Guo1, Shiquan Wang1, Fei Shen1, Xuesha Xing1, Yang Luo2.   

Abstract

CDK2 (cyclin-dependent kinase 2), a member of the CDK family, has been shown to play a role in many cellular activities including cell cycle progression, apoptosis and senescence. Recently, accumulating evidence indicates that CDK2 is involved in DNA damage and DNA repair response (DDR). When DNA is damaged by internal or external genotoxic stresses, CDK2 activity is required for proper DNA repair in vivo and in vitro, whereas inactivation of CDK2 by siRNA techniques or by inhibitors could result in DNA damage and stimulate DDR. Hence, CDK2 seems to play dual roles in DNA damage and DDR. On one aspect, it is activated and stimulates DDR to repair DNA damage when DNA damage occurs; on the other hand, its inactivation directly leads to DNA damage and evokes DDR. Here, we describe the roles of CDK2 in DNA damage and DDR, and discuss the potential application of CDK2 inhibitors as anti-cancer agents.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  CDK2; Cancer treatment; DNA damage; DNA damage response (DDR)

Year:  2019        PMID: 31731257     DOI: 10.1016/j.dnarep.2019.102702

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  4 in total

1.  Role of Genetic Variations in CDK2, CCNE1 and p27KIP1 in Prostate Cancer.

Authors:  Márk Híveš; Jana Jurečeková; Ján Kliment; Marián Grendár; Peter Kaplán; Róbert Dušenka; Daniel Evin; Marta Vilčková; Klaudia Híveš Holečková; Monika Kmeťová Sivoňová
Journal:  Cancer Genomics Proteomics       Date:  2022 May-Jun       Impact factor: 4.069

2.  MicroRNA-122-5p inhibits cell proliferation, migration and invasion by targeting CCNG1 in pancreatic ductal adenocarcinoma.

Authors:  Chen Dai; Yan Zhang; Zhihua Xu; Mengxian Jin
Journal:  Cancer Cell Int       Date:  2020-03-30       Impact factor: 5.722

3.  LINC00265 Promotes Metastasis and Progression of Hepatocellular Carcinoma by Interacting with E2F1 at The Promoter of CDK2.

Authors:  Beihai Ge; Xian Zhang; Wei Zhou; Yun Mo; Z Hou Su; Guolong Xu; Qiang Chen
Journal:  Cell J       Date:  2022-06-29       Impact factor: 3.128

4.  Transcriptional CDK inhibitors, CYC065 and THZ1 promote Bim-dependent apoptosis in primary and recurrent GBM through cell cycle arrest and Mcl-1 downregulation.

Authors:  Viktorija Juric; Lance Hudson; Joanna Fay; Cathy E Richards; Hanne Jahns; Maïté Verreault; Franck Bielle; Ahmed Idbaih; Martine L M Lamfers; Ann M Hopkins; Markus Rehm; Brona M Murphy
Journal:  Cell Death Dis       Date:  2021-08-03       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.